Skip to main content
. 2020 Jul 2;56(1):1901458. doi: 10.1183/13993003.01458-2019

FIGURE 1.

FIGURE 1

a) Example trace of a GSK1016790A 100 ng·mL−1 (153 nM for 15 s) mediated response. Contraction was unchanged following vehicle (6% cyclodextrin in saline) administration (b) but significantly inhibited following administration of GSK2193874 (300 mg·kg−1, i.p.) (c). Data are presented as mean±sem of n=3. *: p<0.05, paired t-test comparing responses before and after antagonist/vehicle administration in the same animal.